For citations:

Shestakova M.V., Dobronravov V.A., Ametov A.S., Antsiferov M.B., Batyushin M.M., Bobkova I.N., Galstyan G.R., Demidova T.Y., Klimontov V.V., Mkrtumyan A.M., Petunina N.A., Prokopenko E.I., Chebotareva N.V., Shamkhalova M.S. Prospects of finerenone use in Russian population of patients with chronic kidney disease and type 2 diabetes. Resolution of multidisciplinary. Advisory board. Diabetes mellitus. 2023;26(5):492-499. (In Russ.) https://doi.org/10.14341/DM13020